(Q40595480)

21 September 2017

Association between the major histocompatibility complex and clinical response to infliximab therapy in patients with Behçet uveitis (English)

1 reference

21 September 2017

0 references

1 reference

Kana Kuroyanagi

1

1 reference

21 September 2017

Tsutomu Sakai

2

1 reference

21 September 2017

Hideo Kohno

3

1 reference

21 September 2017

Kiichiro Okano

4

1 reference

21 September 2017

Goichi Akiyama

5

1 reference

21 September 2017

Ranko Aoyagi

6

1 reference

21 September 2017

Mayumi Inaba

7

1 reference

21 September 2017

Hiroshi Tsuneoka

8

1 reference

21 September 2017

29 August 2015

1 reference

Japanese Journal of Ophthalmology

21 September 2017

1 reference

21 September 2017

59

1 reference

21 September 2017

6

1 reference

21 September 2017

401-408

1 reference

https://scigraph.springernature.com/pub.10.1007/s10384-015-0404-2

21 September 2017

0 references

cites work

Close association of HLA-Bw51 with Behçet's disease

1 reference

https://api.crossref.org/works/10.1007%2FS10384-015-0404-2

Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-015-0404-2

Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-015-0404-2

Multicenter study of infliximab for refractory uveoretinitis in Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-015-0404-2

Psoriasis triggered by infliximab in a patient with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-015-0404-2

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-015-0404-2

High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-015-0404-2

HLA-DRB1 DNA sequencing based typing: an approach suitable for high throughput typing including unrelated bone marrow registry donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-015-0404-2

Association of the major histocompatibility complex with response to infliximab therapy in rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-015-0404-2

Cytokine production profile in patients with Behcet's disease treated with infliximab

21 January 2018

1 reference

12 December 2020

Behçet's disease ocular attack score 24: evaluation of ocular disease activity before and after initiation of infliximab

1 reference

12 December 2020

Recent research into Behçet's disease in Japan

1 reference

12 December 2020

A strong association between HLA-B*5101 and Behçet's disease in Greek patients

1 reference

12 December 2020

Detection of antinuclear antibodies by use of an enzyme immunoassay with nuclear HEp-2 cell extract and recombinant antigens: comparison with immunofluorescence assay in 307 patients.

1 reference

12 December 2020

[Behcet's disease with ocular involvement in Taiwan: a joint survey of six major ophthalmological departments]

1 reference

12 December 2020

Genetic association of HLA-A*2601 with ocular Behçet's disease in Japanese patients

1 reference

12 December 2020

Standardization of vitreal inflammatory activity in intermediate and posterior uveitis

1 reference

12 December 2020

Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis

1 reference

12 December 2020

Four-digit allele genotyping of the HLA-A and HLA-B genes in Japanese patients with Behcet's disease by a PCR-SSOP-Luminex method

1 reference

12 December 2020

10.1007/S10384-015-0404-2

Identifiers

DOI

1 reference

21 September 2017

1 reference